Adverum Biotechnologies
ADVM
ADVM was delisted on the 8th of December, 2025.
76 hedge funds and large institutions have $153M invested in Adverum Biotechnologies in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 25 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
7.86% less ownership
Funds ownership: 67.69% → 59.83% (-7.9%)
17% less funds holding
Funds holding: 92 → 76 (-16)
28% less call options, than puts
Call options by funds: $1.57M | Put options by funds: $2.18M
43% less capital inflows, than outflows
Capital inflows: $18.3M | Capital outflows: $31.8M
76% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Numeric Investors
Boston,
Massachusetts
|
+$3.97M |
| 2 |
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.19M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.7M |
| 4 |
Millennium Management
New York
|
+$1.33M |
| 5 |
Bridgeway Capital Management
Houston,
Texas
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Redmile Group
San Francisco,
California
|
-$6.36M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.33M |
| 3 |
Ascend Capital
Orinda,
California
|
-$2.96M |
| 4 |
VHCP Management
New York
|
-$2.46M |
| 5 |
Frontier Capital Management
Boston,
Massachusetts
|
-$2.31M |
ADVM Hedge Fund Activity: Q4 2015 in Review
76 of the 3,823 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2015, worth a combined $153M — up 6.5% from $144M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ADVM and 6 opened new positions — a net loss of 19 holders — while 26 trimmed existing stakes and 26 added.
The largest buyer was Numeric Investors, adding an estimated $3.97M. The largest seller was Redmile Group, cutting an estimated $6.36M.
- 76 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2015, down from 92 in Q3 2015.
- Funds reported $153M of Adverum Biotechnologies stock for Q4 2015, up 6.5% quarter-over-quarter.
- 6 funds opened new Adverum Biotechnologies positions in Q4 2015 and 25 closed out, a net change of -19 holders.
- The largest Adverum Biotechnologies buyer in Q4 2015 was Numeric Investors, an estimated $3.97M added.
- The largest Adverum Biotechnologies seller in Q4 2015 was Redmile Group, an estimated $6.36M sold.
Based on aggregated 13F filings for Q4 2015.